Wellington Partners
Overview
Wellington Partners is one of the most well recognized European venture capital firms with total funds of € 800 million under management. We have invested in European early stage companies that have the potential to become market leaders.
Investment Focus
- Innovative technology or life sciences companies with high growth potential
- Strong management teams
- Scalable business models
- Clear exit strategies
Portfolio Companies
Reach Wellington Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Wellington Partners
What sectors does Wellington Partners invest in?
Wellington Partners invests in Technology, Software, Life Sciences, Digital Health, Medical Devices and Diagnostics, and is based in Munich, Bavaria, Germany. Wellington Partners is listed as a vc in the ConnectSafely investor database.
What stage does Wellington Partners invest at?
Wellington Partners backs companies at Seed, Early Stage, Growth and Late Stage, writing cheques of 500K - 20M.
Which regions does Wellington Partners invest in?
Wellington Partners invests across United States, United Kingdom, Germany and Switzerland.
Who are the partners at Wellington Partners?
Team members listed for Wellington Partners include Rainer Strohmenger (Managing Partner) and Harald Keller (Partner).
What companies has Wellington Partners invested in?
Wellington Partners's portfolio includes Rigontec, Oxford Immunotec, Themis, Definiens, Actelion, Immatics, Invendo and MTM Laboratories.
How do I contact Wellington Partners?
Wellington Partners's contact details — including work email, phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database